drugset / Trial / NCT00112749
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Phase 2
Terminated
7 enrolled
Jonsson Comprehensive Cancer Center
American Cancer Society, Inc. · collab
NaSingle-groupOpen-labelSupportive care
Summary
RATIONALE: Infliximab may help improve energy levels in patients who have undergone treatment for breast cancer. PURPOSE: This phase II trial is studying how well infliximab works in treating cancer-related fatigue in postmenopausal women who have undergone treatment for stage 0, stage I, or stage II breast cancer.
Timeline
- Start
- 2005-02
- Primary completion
- 2007-01
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | 1 mg/kg | Intravenous |